<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="8321">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02028104</url>
  </required_header>
  <id_info>
    <org_study_id>NGBSI-06</org_study_id>
    <nct_id>NCT02028104</nct_id>
  </id_info>
  <brief_title>Stem Cell Therapy in Traumatic Brain Injury</brief_title>
  <official_title>Open Label Study of Autologous Bone Marrow Mononuclear Cells in Traumatic Brain Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Neurogen Brain and Spine Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Neurogen Brain and Spine Institute</source>
  <oversight_info>
    <authority>India: Indian Council of Medical Research</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study was to study the effect of stem cell therapy on common symptoms in
      patients with Traumatic Brain Injury
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2010</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">January 2015</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Change in clinical symptoms of traumatic brain injury</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Disability Rating scale</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>SF-8 scale</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Traumatic Brain Injury</condition>
  <arm_group>
    <arm_group_label>stem cells</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>autologous bone marrow mononuclear cell transplantation</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Autologous bone marrow mononuclear cell transplantation</intervention_name>
    <description>bone marrow derived mononuclear cells are administered intrathecally in traumatic brain injury patients</description>
    <arm_group_label>stem cells</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosed cases of chronic traumatic brain injury

          -  Age above 6 months

        Exclusion Criteria:

          -  presence of acute infections such as Human immunodeficiency virus/Hepatitis B -
             Virus/Hepatitis C Virus

          -  malignancies

          -  bleeding tendencies

          -  pneumonia

          -  renal failure

          -  severe liver dysfunction

          -  severe anemia [Hemoglobin &lt; 8]

          -  any bone marrow disorder

          -  space occupying lesion in brain

          -  other acute medical conditions such as respiratory infection and pyrexia

          -  pregnancy

          -  lactation
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alok K Sharma, M.S., M.Ch</last_name>
    <role>Principal Investigator</role>
    <affiliation>Neurogen Brain and Spine Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alok K Sharma, M.S, M.Ch</last_name>
    <phone>91-22-25281610</phone>
    <email>alok276@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Neurogen brain and spine institute</name>
      <address>
        <city>Mumbai</city>
        <state>Maharashtra</state>
        <zip>400071</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alok K Sharma, M.S, M.Ch.</last_name>
      <phone>91-22-25281610</phone>
      <email>alok276@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <reference>
    <citation>Lee DH, Lee JY, Oh BM, Phi JH, Kim SK, Bang MS, Kim SU, Wang KC. Functional recovery after injury of motor cortex in rats: effects of rehabilitation and stem cell transplantation in a traumatic brain injury model of cortical resection. Childs Nerv Syst. 2013 Mar;29(3):403-11. doi: 10.1007/s00381-012-1969-4. Epub 2012 Nov 24.</citation>
    <PMID>23180314</PMID>
  </reference>
  <reference>
    <citation>Tian C, Wang X, Wang X, Wang L, Wang X, Wu S, Wan Z. Autologous bone marrow mesenchymal stem cell therapy in the subacute stage of traumatic brain injury by lumbar puncture. Exp Clin Transplant. 2013 Apr;11(2):176-81. doi: 10.6002/ect.2012.0053. Epub 2012 Aug 11.</citation>
    <PMID>22891928</PMID>
  </reference>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 3, 2014</lastchanged_date>
  <firstreceived_date>January 3, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>No</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
